Differential c-myc protein expression in Burkitt's lymphomas and EBV-transformed lymphoblastoid lines

Eur J Cancer. 1991;27(12):1643-5. doi: 10.1016/0277-5379(91)90436-h.

Abstract

The levels of c-myc protein expression in three types of Epstein-Barr virus (EBV) transformed human B-cell derived lines were examined with an ELISA assay. Six independently maintained sublines of the same EBV-transformed pro-B-cell line (FLEB-14), six B-cell lines (LCL) and six Burkitt's lymphoma lines (BL) were compared. The average amount of c-myc protein, calculated from at least three independent tests on each line, differed between the three groups. Expressed in relative units, the ratio of the means was 1:2:5 for the LCL:FLEB:BL lines. The differences were statistically significant at P less than 0.01.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • B-Lymphocytes / metabolism
  • Burkitt Lymphoma / genetics
  • Burkitt Lymphoma / metabolism*
  • Cell Line
  • Cell Transformation, Viral / physiology
  • Down-Regulation
  • Enzyme-Linked Immunosorbent Assay
  • Gene Expression Regulation, Viral
  • Humans
  • Proto-Oncogene Proteins c-myc / analysis*

Substances

  • Proto-Oncogene Proteins c-myc